Sweden's Acarix Q2 revenue more than doubles, net loss narrows
Sweden's Acarix Q2 revenue more than doubles, net loss narrows
Overview
Sweden cardiac diagnostics firm's Q2 revenue more than doubled yr/yr, driven by U.S. growth
Company delivered 29 CADScor Systems in Q2, up 53% yr/yr
Q2 net loss narrowed 26% as operating costs fell
Outlook
Company did not provide specific guidance for the current or future periods in press release
Result Drivers
U.S. GROWTH - Revenue gains were primarily driven by a 212% increase in U.S. sales, according to CEO Aamir Mahmood
SYSTEM DELIVERIES - Q2 saw a 53% increase in CADScor System deliveries, expanding the installed base
OPERATING EFFICIENCY - Operating costs fell 19% in Q2, contributing to a narrower net loss
Company press release: ID:nMFN2g8Bb8
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue |
| SEK 2.31 mln |
|
Q2 Loss Per Share |
| SEK 0.01 |
|
Q2 Gross Margin |
| 84.00% |
|
Reuters Recommended Reads
Aug 12 - QT Imaging Q2 revenue more than doubles
Aug 11 - Stereotaxis Q2 revenue misses estimates, dragged by system decline
Aug 13 - Sweden's RaySearch Q2 order intake rises on clinical adoption
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)